New Combination Therapy Shows Promise for Rare Leukemia in Multicenter Study
A multicenter retrospective study published in Nature Health Sciences evaluated the VDVD drug regimen as an induction therapy for acute leukaemia of ambiguous lineage (ALAL), reporting high overall response rates.
Key points
- Evaluated a novel four-drug regimen (VDVD) for rare acute leukaemia of ambiguous lineage (ALAL)
- Involved 19 patients across eight medical centers with a median age of 58
- Observed a high overall response rate of nearly 95% after one induction cycle
A recent multicenter retrospective study published in Nature Health Sciences investigated the use of a novel drug regimen—known as VDVD—for patients diagnosed with de novo acute leukaemia of ambiguous lineage (ALAL), a rare and complex form of blood cancer. Researchers across eight hospitals in China evaluated 19 patients, with a median age of 58, who received the treatment comprising venetoclax, multi-frequency decitabine, vincristine, and dexamethasone. Dasatinib was additionally administered to patients who tested positive for the BCR::ABL1 genetic marker.
According to the findings, the overall response rate reached nearly 95 percent after a single induction cycle, with an 84 percent complete remission rate. The study noted no induction-related deaths, and secondary endpoints tracked overall survival, event-free survival, and disease-free survival over a median follow-up of 11 months.
Because ALAL typically carries unsatisfactory outcomes under conventional chemotherapy, these early findings suggest that the VDVD regimen may offer a manageable safety profile and notable efficacy. However, the study was a small, retrospective investigation, meaning larger clinical trials are necessary to confirm these results and determine long-term outcomes.
What to know: The VDVD therapy combines multiple agents to target rare leukemia, but findings are preliminary. Always consult a qualified healthcare provider for personalized medical decisions and treatment planning.
Source Nature Health Sciences — nature.com/articles/s41598-026-79095-9 ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.